Kraft Davis & Associates LLC Sells 32 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Kraft Davis & Associates LLC cut its position in UnitedHealth Group Incorporated (NYSE:UNH) by 5.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 545 shares of the healthcare conglomerate’s stock after selling 32 shares during the quarter. Kraft Davis & Associates LLC’s holdings in UnitedHealth Group were worth $274,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the company. Robbins Farley acquired a new position in UnitedHealth Group during the third quarter worth about $25,000. Richelieu Gestion SA bought a new position in UnitedHealth Group in the 4th quarter valued at approximately $26,000. CGC Financial Services LLC grew its stake in shares of UnitedHealth Group by 1,000.0% during the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 50 shares during the last quarter. NewSquare Capital LLC raised its position in UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 51 shares during the last quarter. Finally, LFA Lugano Financial Advisors SA grew its holdings in shares of UnitedHealth Group by 148.1% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after purchasing an additional 40 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Ratings Changes

UNH has been the topic of a number of research reports. Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. TD Cowen cut their price target on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a research note on Wednesday, April 10th. Wells Fargo & Company decreased their price target on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a report on Monday, April 8th. Morgan Stanley reduced their target price on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a research note on Friday, April 5th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, April 10th. Four equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $570.05.

UnitedHealth Group Stock Performance

Shares of UNH traded up $7.95 during trading hours on Friday, hitting $501.13. The company’s stock had a trading volume of 6,618,600 shares, compared to its average volume of 5,233,813. The business has a 50 day simple moving average of $488.63 and a two-hundred day simple moving average of $515.13. The company has a market cap of $462.01 billion, a price-to-earnings ratio of 30.64, a PEG ratio of 1.35 and a beta of 0.54. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $554.70. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The firm had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same period last year, the company earned $6.26 earnings per share. On average, equities analysts expect that UnitedHealth Group Incorporated will post 27.74 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.50%. UnitedHealth Group’s dividend payout ratio is currently 45.97%.

Insider Buying and Selling at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.